SRAX, Inc. · OTC:SRAX
SRAX — FY2021 Earnings Presentation
20 slides from SRAX's earnings presentation, Jun 6, 2022
Slide 1: Full Year 2021
(Nasdaq: SRAX) Full Year 2021 Powered by Sequire
Slide 2: Safe Harbor Statement
Safe Harbor Statement: This presentation contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Words or expressions such as "anticipate," "plan,
Slide 3: SRAX offers a host of products for public companies
SRAX offers a host of products with all the tools you need to help your public company thrive — whether you want to obtain more investors, increase shareholder retention, conduct media campaigns, host better company events, or get noticed by the investment community.
Slide 4: Total Sequire Employees
Total Sequire Employees 153
Slide 5: Major Accomplishments
Full year revenue growth of 341% vs. prior year Fourth quarter revenue growth of 170% and 27% vs. prior year and Q3 2021, respectively. Achieved full year revenue target of $31.5M on a pro forma basis to include BIGtoken’s operations. SRAX 4Q and full year Adjusted EBITDA of $865K and $3.8m 13 Quart
Slide 6: SRAX Pro forma revenues
SRAX Pro forma revenues SRAX PRO FORMA REVENUE Change (Unaudited) FY 2021 FY 2020 $ % Sequire revenue 341% 26,357,000 5,976,000 20,381,000 ● Pro forma revenues of $32m Conference revenue 144% 1,229,000 503,000 726,000 ● BIGtoken revenues of $3.4m Other revenues - n/a 964,000 964,000 reflected in dis
Slide 7: Sequire Bookings
Sequire Bookings $16,500,000 $15,600,000 Bookings Projected $12,500,000 $14,000,000 $11,445,437 $12,000,000 $9,288,748 $8,900,000 $10,000,000 $6,634,844 $8,000,000 $4,806,400 $6,000,000 $2,569,198 $4,000,000 $792,000 $2,000,000 $0 Q1 2020 Q2 2020 Q3 2020 Q4 2020 Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 20
Slide 8: Revenue and EBITDA
Revenue and EBITDA 2020 2021 Revenue EBITDA $9,600,000 $10,000,000 $7,548,000 $8,000,000 $6,828,000 $1,403,000 $973,000 $865,000 $6,000,000 $563,000 $4,587,000 $4,000,000 $3,476,000 $1,955,312 $2,000,000 $746,000 $107,000 $217,000 $1,506,000 $1,473,000 $1,570,000 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 | Q4 2021 Fu
Slide 9: Subscribers Over Time
& seouire Subscribers Over Time 183 ' lt Q12020 Q22020 32020 Q42020 Q12021 22021 32021 42021 102022 phy
Slide 10: Share Structure
Share Structure As of today SRAX Common stock Shares Shares Outstanding 26,226,401 Convertible Debentures Due 06/30/2023 392,193 Warrants Expiration 2021 2022 3,602,516 2023 2024 + 100,563 Total 3,729,069 Employee Options 899,287 Fully Diluted Shares 31,246,950
Slide 11: Warrants by Month
Warrants by Month Warrant insights Insights by year Stock price | 3.83 Expiring on 2022 Expiring on 2023 Expiring on 2024 Total warrants $6,966,548.94 $0.00 $0.00 $6,966,548.94 Shares: 3,628,506 Shares: 0 Shares: 100,563 Shares: 3729,059 Expiring 2022 v] | Value in shares 4M 35M 3M 20m = 6 15M 1M 50
Slide 12: Financial Review
Financial Review | Q4 2021 Earnings Call
Slide 13: SRAX 4Q Financials
SRAX 4Q Financials STATEMENT OF OPERATIONS (Unaudited) Q/Q Y/Y In dollars Q4-2020 Q3-2021 Q4-2021 $ CHG % CHG $ CHG % CHG REVENUE Total Revenue 3,554,000 7,548,000 9,587,000 2,039,000 27% 6,033,000 170% COSTS AND EXPENSES Total cost of revenues 892,000 1,597,000 2,102,000 505,000 32% 1,210,000 136%
Slide 14: SRAX Full Year 2021 Financials
SRAX Full Year 2021 Financials (Unaudited) In dollars FY-2021 FY-2020 $ CHG % CHG REVENUE Total revenues 28,550,000 6,479,000 22,071,000 341% COSTS AND EXPENSES Total cost of revenues 6,294,000 1,789,000 4,505,000 252% Employee related costs 7,577,000 4,683,000 2,894,000 62% Marketing and selling ex
Slide 15: BIGToken Deconsolidation
BIGToken Deconsolidation BIGToken - Discontinued Operations Revenues 3,431,000 Costs of sales (1,090,000) Discontinued Operations: Operating Expenses (9,587,000) Non-cash charges reflect BIGToken’s Other (loss) income (7,130,000) BIGtoken - Net (loss) income (14,376,000) operations through 12/31/202
Slide 16: Non-GAAP to GAAP Reconciliations
NON-GAAP TO GAAP RECONCILIATIONS (Unaudited) In dollars FY 2021 FY 2020 $ CHG % CHG Net (loss) income attributable to common stockholders (GAAP) (34,322,000) (14,705,000) (19,617,000) -133% Financing costs, net 10,253,000 12,150,000 (1,897,000) -16% Gain (loss) on marketable securities 8,762,000 (94
Slide 17: Sequire Security Portfolio - Pro forma
Sequire Security Portfolio - Pro forma $23.2 SEQUIRE Security +$2.1 Portfolio +$1.2 $19.9 ● Due to GAAP accounting rules approximately $3.3m in securities at FMV are not recognized. ● Accounting principles require securities to be issued in Company’s name for recognition. 4Q 2021 Shares Reset 4Q 202
Slide 18: Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets | Q4 2021 Earnings Call
Slide 19: Q&A
Q&A SRA SK [3 2021 Earnings Call
Slide 20: Thank you
Thank you | Q3 2021 Earnings Call